Limited uptake mechanism studies with CRANAD-2:
A small molecule across cell-membrane can be mediated by simple diffusion and facilitated diffusion/transport. Fast simple diffusion often leads to non-specific uptake, and highly hydrophobic compounds prone to cross the cell membrane through the fast simple diffusion 1 . From our screening, most of the tested 38 dyes were highly hydrophobic. However, only CRANAD-2, -3, and Nile blue provided positive or negative contrasts, suggesting that the simple diffusion caused by high hydrophobicity was not the only factor in determining the BAT contrast, and facilitated diffusion/transport of CRANAD-2 and -3 into BAT was also very possible. To investigate the facilitated transporting of CRANAD-2, we compared the time courses of CRANAD-2 uptake in 3T3-L1 cells before and after differentiation. The uptake reached its maximal within 1 minute with undifferentiated 3T3-L1 cells (SI Fig.5a , left), indicating that the uptake is most likely due to simple diffusion. For differentiated 3T3-L1 cells, the uptake reached 62% of the maximal within 1 minute, and reached the plateau at 15 minute (SI Fig.5a , right), suggesting that partial accumulation of CRANAD-2 is likely due to facilitated diffusion mediated by receptors/transolcases expressed in differentiated 3T3-L1 cells, but not in preadipocytes. Nile blue, the negative contrast probe, rapidly reached the plateau in both differentiated and undifferentiated 3T3-L1 cells, suggesting that its uptake was primarily due to the fast simple diffusion (SI Fig.6a, b ).
Through systemic comparison of gene expression in undifferentiated and
differentiated 3T3-L1 cells, Sandoval et al found that CD36 was only present in differentiated cells but not in the preadipocytes 2 . CD36 is highly expressed on the surface of adipose cells and endothelial cells of capillaries in adipose tissue, but not on other large vessels and brain capillaries [3] [4] [5] [6] . Recently, Bartelt et al reported that BAT regulates the metabolism of triglyceride through CD36 uptake 7, 8 . Since CRANAD-2, like triglyceride, accumulates in oil droplets, we hypothesized that triglyceride and our curcumin analogues may share the same transporter/translocase. To test this hypothesis, we added both triglyceride and CRANAD-2 to the cell medium, and CRANAD-2 only was used as the control. A significant decrease in uptake was observed for the mixture of CRANAD-2 and triglyceride, evidenced by two-photon microscopy and quantitative imaging with IVIS imaging system (SI Fig.5b-d) . However, no significant decrease in X. Zhang, C. Ran et al, Curcumin analogues as imaging probes for brown adipose tissue 3 uptake was observed for Nile Blue (SI Fig.5c and SI Fig.6c ). These results indicated that triglyceride inhibited the uptake of CRANAD-2, probably due to binding competition for CD36. In addition, Wang et al showed that rosmarinic acid was a high affinity ligand for CD36 9 . Very interestingly, the structure of rosmarinic acid is very similar to curcumin.
These data suggested that curcumin and its analogues are possible ligands for CD36.
However, more comprehensive mechanism studies are still needed.
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